Kestra Medical Technologies, Ltd.
KMTS
$21.00
$0.592.89%
| 10/31/2024 | 07/31/2024 | 10/31/2023 | |||
|---|---|---|---|---|---|
| Revenue | 13.75M | 13.75M | 4.74M | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | 13.75M | 13.75M | 4.74M | ||
| Cost of Revenue | 8.73M | 8.73M | 5.70M | ||
| Gross Profit | 5.02M | 5.02M | -957.50K | ||
| SG&A Expenses | 20.34M | 20.34M | 17.46M | ||
| Depreciation & Amortization | -- | -- | -- | ||
| Other Operating Expenses | -- | -- | -- | ||
| Total Operating Expenses | 32.53M | 32.53M | 27.13M | ||
| Operating Income | -18.78M | -18.78M | -22.38M | ||
| Income Before Tax | -20.46M | -20.46M | -25.09M | ||
| Income Tax Expenses | 7.50K | 7.50K | 18.50K | ||
| Earnings from Continuing Operations | -20.47M | -20.47M | -25.11M | ||
| Earnings from Discontinued Operations | -- | -- | -- | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | 346.00K | 346.00K | -- | ||
| Net Income | -20.13M | -20.13M | -25.11M | ||
| EBIT | -18.78M | -18.78M | -22.38M | ||
| EBITDA | -16.66M | -16.66M | -20.04M | ||
| EPS Basic | -217.18 | -217.18 | -251.08 | ||
| Normalized Basic EPS | -117.61 | -117.61 | -140.18 | ||
| EPS Diluted | -217.18 | -217.18 | -251.08 | ||
| Normalized Diluted EPS | -117.61 | -117.61 | -140.18 | ||
| Average Basic Shares Outstanding | 105.80K | 105.80K | 105.80K | ||
| Average Diluted Shares Outstanding | 105.80K | 105.80K | 105.80K | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | -- | -- | -- | ||
